Our comprehensive analysis revealed that TMEM41A overexpression was associated with shorter OS, clinical stage, age, DSS, weight, histological subtype, PFI, tumor grade, race, and menopausal status in patients with EC. This evidence concerns the gene TMEM41A and neoplasm.